Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Kuehne+Nagel has boosted its healthcare logistics in India by opening a new temperature-controlled airfreight facility in Hyderabad.

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...

Over the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...

The modern and high capacity vaccine manufacturing facility, the Integrated Vaccine Complex, is lying unutilised, Stalin said in a letter t...

Investing in upgrading a BSL-3 lab to make it fit for production will have uses beyond the manufacture of Covaxin. Going beyond the financi...

Kazakhstan, Central Asia’s biggest state and India’s largest trade partner in the region, is open to the idea of both purchasing vaccines f...